用加拿大安大略省的行政卫生数据在日常实践中为患者描述黑色素瘤诊断途径:基于人口的研究
Meaghan E Mavor1,2, Patti A Groome3,2, Yuka Asai4
1Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute, Queen's University, Kingston, Ontario, Canada meaghan.mavor@queensu.ca.
BMJ open
|January 31, 2025
概括
确定了四条黑色素瘤诊断途径,其中"仅初级保健"路径显示了最短的诊断间隔 (DI). 这突显了初级保健的重要意义.
科学领域:
- 皮肤病学和瘤学
- 医疗保健服务研究 医疗服务研究
- 流行病学 流行病学
背景情况:
- 在常规实践中,黑色素瘤诊断途径的特征并不清楚.
- 了解这些途径对于改善患者结果和医疗保健效率至关重要.
研究的目的:
- 在日常实践中对黑色素瘤患者的诊断途径进行表征.
- 在已识别的途径中比较患者,疾病和诊断间隔 (DI) 特性.
主要方法:
- 使用加拿大安大略省 (2007-2019) 的行政卫生数据进行的描述性横截面研究.
- 潜在类集群分析确定了四种不同的诊断途径.
- 分析包括患者病史,表现,程序,访问频率和诊断间隔.
主要成果:
- 确定了四种途径:"仅限初级护理"",转诊专家立即采取行动"",多次访问专家护理"和"仅限专家护理".
- 跨途径患者,疾病和DI特征的显著变化.
- 中位数DI在1至67天之间;最短的DI是"仅初级保健",最长的DI是"多次专业护理".
结论:
- "只有初级保健"路径表明初级保健在早期黑色素瘤诊断中的关键作用.
- 需要减少专家等待时间,以优化诊断间隔.
- 诊断过程的地理差异需要进一步研究护理的效率和适当性.
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Kaplan-Meier Approach
80
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
80


